January 24, 2025 Indian drugmaker Dr Reddy's shares slide after Q3 profit miss Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...
Tesla has launched a limited version of its Full Self-Driving features in China to mixed reviews as it’s still far from what was promised. After many delays, Tesla has now pushed an update that ...
Ltd and Orchid Pharma Ltd are among the other gainers in the BSE's 'A' group today, 24 February 2025. Neuland Laboratories Ltd spiked 10.62% to Rs 12164.7 at 11:47 IST. The stock was the biggest ...
Motilal Oswal Financial Services recommends buying Ipca Laboratories with a target price of Rs 1980. The company reported strong quarterly financial growth, with a rise in total income and net profit.
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from 2025 ...
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...
In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of ...
Neon is partnering with independent bookstores in New York City and Los Angeles to give away free limited edition prints of Sean Baker‘s Academy Award-nominated screenplay of Anora. The ...
Noida (Uttar Pradesh) [India], February 14: Creative OZ-AIR India Pvt Ltd., one of the leading organisation in Ozone, UV, AOP Technology and Air purification solutions, unveils its new logo ...
In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Bio-Rad Laboratories (BIO – Research Report), with a price target of $447.00. The company’s shares ...
Morgan Stanley analyst Rahul Anand maintained a Buy rating on Pilbara Minerals Limited (PILBF – Research Report) today and set a price target of A$2.70. The company’s shares closed yesterday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results